A Resource for Healthcare and Social Services Professionals
November 16, 2020
8:00 am–12:00 pm ET
This 8-hour course prepares nurses and other medical staff to manage office-based addiction treatment with buprenorphine and naltrexone.
Via Zoom
This course will prepare nurses and other key members of the multidisciplinary care team to deliver medication for opioid use disorder (MOUD), such as buprenorphine and naltrexone, using a chronic care management model. Topics covered will include the science of addiction as a brain disorder, the pharmacotherapy of medications used to treat opioid and alcohol use disorders (current standard of care), and practical tools for implementing these treatment modalities into an office-based setting and for supporting physicians or other clinicians as part of a care team. Attendees will learn to screen patients for substance use disorders, initiate medication, and provide ongoing care and counseling.
THIS TRAINING IS BEING HELD VIA ZOOM TELECONFERENCING TECHNOLOGY. In order to receive CE credit, you must have video enabled and turned on when you join the meeting so we can see your face, in addition to registering through this page. The password for this Zoom link will be emailed to you ahead of the training.
Nurses and other clinical staff providing treatment for substance use disorders in an office-based setting.
The learner will: Define opioid use disorder; Explain methods used to evaluate patients for treatment with buprenorphine and injectable naltrexone; Identify the clinically relevant pharmacological characteristics of buprenorphine and buprenorphine/naloxone; and Outline tools for monitoring and supporting patients engaged in Medication for Opioid Use Disorder (MOUD).
Boston Medical Center Grayken Center for Addiction, Department of Public Health, Bureau of Substance Addiction Services
Boston Medical Center grants 7.75 hours to all RNS who complete this program (both parts 1 and 2. You must stay for the entire program, complete pre- and post-testing, and complete an evaluation form. Boston Medical Center is approved as a provider of continuing professional development by American Nurses Association, Massachusetts, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.
Grayken Center for Addiction TTA is a program of Boston Medical Center (BMC), a 514-bed academic medical center located in Boston's historic South End and the largest safety-net hospital in New England.
The content on this site and the content presented by Grayken Center for Addiction TTA is intended solely to inform and educate healthcare and social service professionals, and shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional. The hospital, the program, and the contributors are not acting as health care providers or professional consultants on behalf of any specific patient and disclaim establishing a provider-patient relationship with any specific patient.